Insider · CIK 0001967669

Ben Yong

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001967669

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	BBOTBridgeBio Oncology Therapeutics, Inc.F Tax Payment	Chief Med & Dev Officer	FTax Payment	−1,047 sh	$3.94	−$4,125.18	43,529
2026-09-14	CRBPCorbus Pharmaceuticals Holdings, Inc.S Sale	Director	SSale	−2,000 sh	$7.84	−$15.7K	9,383
2026-07-01	BBOTBridgeBio Oncology Therapeutics, Inc.F Tax Payment	Chief Med & Dev Officer	FTax Payment	−1,047 sh	$7.80	−$8,166.6	44,576
2026-05-19	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock options (right to buy)A Award	Director	AAward	+12.3K sh	—	—	12,300
2026-05-19	CRBPCorbus Pharmaceuticals Holdings, Inc.A Award	Director	AAward	+3,800 sh	—	—	11,383
2026-04-01	BBOTBridgeBio Oncology Therapeutics, Inc.F Tax Payment	Chief Med & Dev Officer	FTax Payment	−1,047 sh	$9.03	−$9,454.41	45,623
2026-03-10	BBOTBridgeBio Oncology Therapeutics, Inc.A Award	Chief Med & Dev Officer	AAward	+46.7K sh	—	—	46,670
2026-03-10	BBOTBridgeBio Oncology Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Med & Dev Officer	AAward	+210K sh	—	—	210,000
2025-08-26	BBOTBridgeBio Oncology Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Med & Dev Officer	AAward	+357K sh	—	—	357,177
2025-05-30	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock options (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2025-05-30	CRBPCorbus Pharmaceuticals Holdings, Inc.A Award	Director	AAward	+4,800 sh	—	—	7,583
2024-05-30	CRBPCorbus Pharmaceuticals Holdings, Inc.A Award	Director	AAward	+2,783 sh	—	—	2,783
2024-05-16	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,783 sh	—	—	2,783
2023-05-18	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,300 sh	—	—	5,300
2023-03-06	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option(right to buy)A Award	Director	AAward	+5,307 sh	—	—	5,307

Recent filings

Accepted (ET)
Oct 54
Ben Yong0001193125-26-414123
SEC(opens sec.gov)
Sep 154
Ben Yong0001193125-26-392093
SEC(opens sec.gov)
Jul 64
Ben Yong0001193125-26-296502
SEC(opens sec.gov)
May 214
Ben Yong0001193125-26-234850
SEC(opens sec.gov)
May 54
Ben Yong0001193125-26-207041
SEC(opens sec.gov)
Mar 124
Ben Yong0001193125-26-104369
SEC(opens sec.gov)
Aug 284
Ben Yong0000950170-25-111997
SEC(opens sec.gov)
Jun 24
Ben Yong0000950170-25-080312
SEC(opens sec.gov)
Jun 34
Ben Yong0000950170-24-068013
SEC(opens sec.gov)
May 204
Ben Yong0001209191-24-005671
SEC(opens sec.gov)
May 224
Ben Yong0001209191-23-031448
SEC(opens sec.gov)
Mar 74
Ben Yong0001209191-23-016575
SEC(opens sec.gov)

Companies

Address

BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. 256 EAST GRAND AVENUE, SUITE 104

SOUTH SAN FRANCISCO, CA, 94080